Expression of angiotensin I-converting enzymes and bradykinin B2 receptors in mouse inner medullary-collecting duct cells

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 254-260

  Redublo Quinto, Beata Marie ^a   Camargo de Andrade, Maria Claudina ^a   Ronchi, Fernanda Aparecida ^a   Santos, Edson Lucas ^b   Alves Correa, Silvana Aparecida ^b   Shimuta, Suma Imura ^b   Pesquero, João Bosco ^b   Mortara, Renato Arruda ^c   Casarini, Dulce Elena ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Unversidade Federal de Sao Paulo   (Brazil)

^c Disciplina de Nefrologia   (Brazil)

Author keywords

Angiotensin I converting enzyme; Bradykinin; Kinin receptors; mIMCD 3 cells

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRILAT; KALLIKREIN; KININ;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL NUCLEUS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; ENZYME INHIBITION; IMMUNOFLUORESCENCE; KIDNEY COLLECTING TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CAPTOPRIL; CELLS, CULTURED; ENALAPRILAT; FLUORESCENT ANTIBODY TECHNIQUE; KIDNEY MEDULLA; KIDNEY TUBULES, COLLECTING; MICE; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, BRADYKININ B2;

EID: 37549037458     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.09.013     Document Type: Article

References (42)

1. Ehlers M.R., and Riordan J.F. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 28 (1989) 5311-5318
2. Casarini D.E., Boim M.A., Stella R.C., Krieger-Azzolini M.H., Krieger J.E., and Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 272 (1997) F405-F409
3. Ebihara F., Di Marco G.S., Juliano M.A., and Casarini D.E. Neutral endopeptidase expression in mesangial cells. J Renin Angiotensin Aldosterone Syst 4 (2003) 228-233
4. Leite C.A., Cristovam P.C., Leitao A.A., Miranda A., Andrade M.C., Di Marco G., et al. Renin similar to the submaxillary gland form is expressed in mouse mesangial cells: subcellular localization and all generation under control and glucose-stimulated conditions. Cell Physiol Biochem 13 (2003) 357-366
5. Andrade M.C., Quinto B.M., Carmona A.K., Ribas O.S., Boim M.A., Schor N., et al. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture. J Hypertens 16 (1998) 2063-2074
6. Camargo de Andrade M.C., Di Marco G.S., de Paulo Castro Teixeira V., Mortara R.A., Sabatini R.A., Pesquero J.B., et al. Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Renal Physiol 290 2 (2006) F364-F375 [Erratum in: Am J Physiol Renal Physiol. 2006;291(4):F921.]
7. Vidotti D.B., Casarini D.E., Cristovam P.C., Leite C.A., Schor N., and Boim M.A. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 286 (2004) F1039-F1045
8. Komlosi P., Fuson A.L., Fintha A., Peti-Peterdi J., Rosivall L., Warnock D.G., et al. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 42 (2003) 195-199
9. Braam B., Mitchell K.D., Fox J., and Navar L.G. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 264 (1993) F891-F898
10. Prieto-Carrasquero M.C., Harrison-Bernard L.M., Kobori H., Ozawa Y., Hering-Smith K.S., Hamm L.L., et al. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44 (2004) 223-229
11. Vio C.P., Loyola S., and Velarde V. Localization of components of the kallikrein-kinin system in the kidney: relation to renal function. State of the art lecture. Hypertension 19 (1992) II10-II16
12. Fuller P.J., and Funder J.W. The cellular physiology of glandular kallikrein. Kidney Int 29 (1986) 953-964
13. Erdos E.G., and Yang H.Y. An enzyme in microsomal fraction of kidney that inactivates bradykinin. Life Sci 6 (1967) 569-574
14. Yang H.Y., Erdos E.G., and Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 214 (1970) 374-376
15. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown Jr. E.J., Cuddy T.E., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
16. Gavras H. Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart. Hypertension 23 (1994) 813-818
17. Lewis E.J. Angiotensin-converting enzyme inhibition in type I diabetic nephropathy. Contrib Nephrol 118 (1996) 206-213
18. Sleight P. The renin-angiotensin: a review of trials with angiotensin-converting enzyme inhibitors and angiotensin receptor blocking agents. Eur Heart J 4 (2002) A53-A57
19. Linz W., Wiemer G., Gohlke P., Unger T., and Scholkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47 (1995) 25-49
20. Carretero O.A., and Scicli A.G. The kallikrein-kinin system as a regulator of cardiovascular and renal function. 2nd ed. (1995), Raven Press Publishers, New York, NY
21. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44 (1992) 1-80
22. Hecker M., Porsti I., Bara A.T., and Busse R. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level. Br J Pharmacol 111 (1994) 238-244
23. Auch-Schwelk W., Bossaller C., Claus M., Graf K., Grafe M., and Fleck E. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin. Cardiovasc Res 27 (1993) 312-317
24. Marcic B., Deddish P.A., Jackman H.L., and Erdos E.G. Enhancement of bradykinin and resensitization of its B2 receptor. Hypertension 33 (1999) 835-843
25. Marcic B., Deddish P.A., Skidgel R.A., Erdos E.G., Minshall R.D., and Tan F. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors. J Biol Chem 275 (2000) 16110-16118
26. Minshall R.D., Tan F., Nakamura F., Rabito S.F., Becker R.P., Marcic B., et al. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells. Circ Res 81 (1997) 848-856
27. Ignjatovic T., Tan F., Brovkovych V., Skidgel R.A., and Erdos E.G. Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol 2 (2002) 1787-1793
28. Rauchman M.I., Nigam S.K., Delpire E., and Gullans S.R. An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am J Physiol 265 (1993) F416-F424
29. Wei Y., and Wang W. Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts. Am J Physiol Renal Physiol 284 (2003) F175-F181
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
32. Andrade M.C., Di Marco G.S., Teixeira V., Morata R., Schor N., and Casarini D.E. Co-localization of N-domain angiotensin I-converting enzyme (ACE) with angiotensin II (AII) and angiotensin 1-7 in mesangial cells from Wistar and spontaneously hypertensive rats (SHR). Nephrol Dial Transplant 18 (2003) 13
33. Casarini D.E., Carmona A.K., Plavnik F.L., Zanella M.T., Juliano L., and Ribeiro A.B. Calcium channel blockers as inhibitors of angiotensin I-converting enzyme. Hypertension 26 (1995) 1145-1148
34. Casarini D.E., Plavinik F.L., Zanella M.T., Marson O., Krieger J.E., Hirata I.Y., et al. Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol 33 (2001) 75-85
35. Deddish P.A., Wang J., Michel B., Morris P.W., Davidson N.O., Skidgel R.A., et al. Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci U S A 91 (1994) 7807-7811
36. Wei L., Alhenc-Gelas F., Corvol P., and Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 266 (1991) 9002-9008
37. Nishimura K., Yoshida N., Hiwada K., Ueda E., and Kokubu T. Properties of three different forms of angiotensin I-converting enzyme from human lung. Biochim Biophys Acta 522 (1978) 229-237
38. Cheung H.S., Wang F.L., Ondetti M.A., Sabo E.F., and Cushman D.W. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. J Biol Chem 255 (1980) 401-407
39. Takada Y., Hiwada K., and Kokubu T. Isolation and characterization of angiotensin converting enzyme from human kidney. J Biochem (Tokyo) 90 (1981) 1309-1319
40. Hattori M.A., Del Ben G.L., Carmona A.K., and Casarini D.E. Angiotensin I-converting enzyme isoforms (high and low molecular weight) in urine of premature and full-term infants. Hypertension 35 (2000) 1284-1290
41. Tom B., Dendorfer A., and Danser A.H. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?. Int J Biochem Cell Biol 35 (2003) 792-801
42. Kohlstedt K., Busse R., and Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension 45 (2005) 126-132